Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Biocartis forum geopend
Volgen
De grafiek van het koersverloop, sinds mei dit jaar, toen ze even boven 12€ stonden, vertoont niet echt een trend die mij vertrouwen geeft. Voor de duidelijkheid, ik ben bezitter van Biocartis aandelen en ik hoop dat het tij gaat keren, maar dan zal de wind toch uit een andere richting moeten gaan waaien.
You are correct that the medium and short term trends are negative. If BCART breaks the support at $9.65 it would be very negative. That said, I tend to look more at fundamentals rather than technical factors. The potential developments I mentioned would change the trajectory in the blink of an eye. Updates on this type of news is most likely to occur in conjunction with the financial results release. I'm thinking that a retest of the $9.65 low will occur in the next two weeks. The early Sept press releases will allow BCART to put a bottom in. FL
Flatlander schreef op 20 augustus 2019 21:48 :
You are correct that the medium and short term trends are negative. If BCART breaks the support at $9.65 it would be very negative. That said, I tend to look more at fundamentals rather than technical factors. The potential developments I mentioned would change the trajectory in the blink of an eye. Updates on this type of news is most likely to occur in conjunction with the financial results release. I'm thinking that a retest of the $9.65 low will occur in the next two weeks. The early Sept press releases will allow BCART to put a bottom in.
FL
Is slechts een kwestie van tijd.
Waarom in godsnaam in fora zitten voor aandelen waar men niet in gelooft ? U bent een expert in molecular diagnostics ? Met opmerkingen van "Biocartis werkt met een verliesmodel" ... lijkt me dit onwaarschijnlijk. DeZwarteRidder schreef op 20 augustus 2019 21:52 :
[...]
Is slechts een kwestie van tijd.
casusanima schreef op 22 augustus 2019 11:42 :
Waarom in godsnaam in fora zitten voor aandelen waar men niet in gelooft ? U bent een expert in molecular diagnostics ? Met opmerkingen van "Biocartis werkt met een verliesmodel" ... lijkt me dit onwaarschijnlijk.
[...]
Het is gewoon gezellig hier met al die Belgen, die denken dat ze een goudmijntje ontdekt hebben.
DeZwarteRidder schreef op 22 augustus 2019 13:00 :
[...]
Het is gewoon gezellig hier met al die Belgen, die denken dat ze een goudmijntje ontdekt hebben.
Is slechts een kwestie van tijd
[Modbreak IEX: Gelieve op de inhoud van uw berichten te letten, bericht is bij dezen verwijderd.]
I agree with your frustration. I appreciate negative opinions and short seller comments. Perhaps there is an angle of my investment in BCART that has overlooked something. Black Knight, please offer an opinion on why some of the events I cite as potential inflection points where sales ramp are incorrect. Even better, back it up with a fact or two. Stupid people don't acknowledge if they overlooked something in their investments. All this said, I've had to curtail adding to my BCART position. The brokerage I use will no longer allow purchases of BCART shares thru a European broker. Trump probably is probably shutting it down in retribution for not selling him Greenland. Never mind that it is Belgium and not the Netherlands. It's all the same in his mind. FL
Meant to say Denmark. Oops
Gezelligheid met Hollanders?Een lege maag,leeg glas & zurigheid.Dat is 'm "De Zwarte Ridder".
Ik heb er nog wat bijgekocht naar aanleiding van het nieuws van deze morgen. Als ze een speciale aandeelhoudersvergadering organiseren om de voorwaarden te wijzigen in geval van change of control, dan speelt het overnamescenario duidelijk mee. De nieuwe CEO heeft natuurlijk ook de reputatie mee om alle bedrijven waar hij CEO was of opgericht heeft op relatief korte termijn te verkopen.
Unusual that Biocartis could be contemplated as an acquisition target given how far its earnings are from being accretive. The GHDX-EXAS combination would be a likely candidate since BCART is central to their EU and rest of world expansion. Is it typical to call a meeting of this nature without releasing specifics? Guess we get the details as we approach Sept 5. You bought the open? You must believe this marks a change. BCART almost always weakens into the market close. FL
My impression is that this was a placeholder announcement. There must be a 30 day notice requirement for such a shareholder meeting and vote. The fact that they notified of the meeting with no specifics suggests that we will see something with more details in the next couple of day. FL
ik vermoed dat we binnekort een feestje kunnen bouwen
Joshua41 schreef op 28 augustus 2019 16:38 :
ik vermoed dat we binnekort een feestje kunnen bouwen
Het is te hopen Joshua41 Nog een paar weken en we weten het antwoord
I googled Article 556 of the Belgian Companies Code of 7 May 1999, iclg.com/practice-areas/mergers-and-a... The discussion under 2.3 makes it sound as if the BCART offering is following the hostile path (i.e., meeting scheduled first). It is quite possible and probably more likely that the share ownership is so widely disseminated that it is impossible to proceed in any other manner. Even if the two biggest shareholders (Invesco and JnJ) agreed it would still be less than 25% of shares. The website suggests that Belgium law may require agreement by 75% of shareholders. I'm probably well out ahead of myself, but it looks like the small shareholders could be important to hit the necessary threshold. Time for me to shut up and wait for BCART to release more details. FL FL
One last rank speculation. What are the top acquisition candidates? My nominees are the following: 1) GH & EXAS 2) Wondfu 3) Fisher Scientific 4) Nichirei Bioscience 5) J n J 6) Philips Medical
Gaat het verkocht worden? Wouw
The reference to Article 556 of the Belgian Companies Code seems to indicate it will be sold. I ruled Kite out based on the fact that the the Kite deal was announced a couple months ago and they have not had sufficient time to prove proof of concept, FL
Symposium by Biocartis and Genomic Health “optimized treatment decisions for personalized medicine”. On 10 September from 13h00 till 14h30 At European Congress of Pathology, Nice France
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee